Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950135-09-002770
Filing Date
2009-04-10
Accepted
2009-04-10 17:14:52
Documents
6
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 INVERNESS MEDICAL INNOVATIONS b73439kae10vkza.htm 10-K/A 2452482
2 EX-23.1 CONSENT OF BDO SEIDMAN, LLP b73439kaexv23w1.htm EX-23.1 2011
3 EX-31.1 SECTION 302 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER b73439kaexv31w1.htm EX-31.1 5774
4 EX-31.2 SECTION 302 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER b73439kaexv31w2.htm EX-31.2 5751
5 EX-32.1 SECTION 906 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINAN b73439kaexv32w1.htm EX-32.1 4157
6 GRAPHIC b73439kab7343901.gif GRAPHIC 8757
  Complete submission text file 0000950135-09-002770.txt   2483837
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16789 | Film No.: 09745467
SIC: 2835 In Vitro & In Vivo Diagnostic Substances